New

Molecular Health

The AI engine Fit Assessment

Beta

The company provides pharma-focused software solutions for drug development and clinical decision support, including Dataome Technology and AI Pharma Solutions, and serves pharmaceutical and biotech companies.

Blurb

Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.

HQ Location

Heidelberg (Germany)

Founded

2004

Employees

51 - 200

Total funding raised

$26.71M

Funding Status

Private Equity, $26.71M, November 16, 2015

Molecular Health is a leading provider of data-driven software technology and solutions. For more than 15 years, Molecular Health has been dedicated to building software solutions that leverage a unique symbiosis of human expertise, state-of-the-art data curation, and deep analytics. Molecular Health's proprietary Dataome technology integrates and contextualizes biomedical, molecular, and drug-related data to provide a profound understanding of the etiology of health and disease conditions. Based on the Dataome technology, Molecular Health offers leading-edge software for analyzing genetic and molecular data as well as Pharma AI solutions to improve early trial design, target identification, as well as indication and biomarker discovery. For more information about Molecular Health, please visit www.molecularhealth.com.